Published in Blood Weekly, May 15th, 2003
The appointment comes at a time when concerns over West Nile virus and blood safety continue to grow in the public consciousness.
The Blood Products Advisory Committee is responsible for ensuring the safe and appropriate use of new products, technologies and medical devices in the treatment and prevention of human blood-based diseases. One of two non-voting "industry representatives," Strong will be a blood services expert on the committee. His appointment was approved by the FDA...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.